Skip to main content
OpenTrials
Completed

NCT Number: NCT07641101

Effects Of App-Supported Transitional Care On Neurogenic Bladder In Spinal Cord Injury Patients

This is a single-blind randomized controlled trial for patients with neurogenic bladder after incomplete spinal cord injury. Participants are randomly divided into two groups. The control group receives routine transitional nursing and telephone follow-up, while the intervention group gets 4-week app-supported transitional care including health education, bladder recording and online consultation. After intervention, bladder residual urine, urinary tract infection rate, self-care ability and quality of life are compared between two groups.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Neurogenic bladder is a common complication after incomplete spinal cord injury, which easily leads to recurrent urinary tract infection and decreased quality of daily life. Traditional transitional follow-up is limited by time and space. This study adopts single-blind parallel-group RCT design. Eligible patients are randomly allocated at a 1:1 ratio. Control group receives standard inpatient nursing plus conventional post-discharge follow-up; intervention group receives identical inpatient care plus systematic app-based transitional care for 4 weeks. Primary outcomes are post-void residual urine volume and urinary tract infection incidence. Secondary outcomes contain self-care ability and quality of life assessed by standardized scales. All indicators are tested at baseline and 4 weeks after intervention to verify the clinical effect of app-assisted transitional nursing.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosed with neurogenic bladder secondary to incomplete spinal cord injury; Age ranging from 18 to 75 years old; Clear consciousness, capable of cooperating with nursing assessment and mobile APP follow-up management; Voluntarily sign written informed consent. -

Exclusion criteria

Combined with severe renal insufficiency, malignant tumor or other life-threatening severe systemic diseases; History of previous bladder reconstructive surgery; Cognitive impairment unable to independently operate mobile APP; Refuse to continue follow-up or withdraw voluntarily during the research period.

-

Treatment and study plan

Mobile Application Based Transitional Care

Behavioral

Four-week continuous transitional nursing service via mobile APP for patients with neurogenic bladder after incomplete spinal cord injury, including disease-related health education, real-time voiding record, regular nursing reminder and online one-on-one nurse consultation, which differs from routine single telephone follow-up in control group.

routine standardized inpatient bladder nursing

Other

routine standardized inpatient bladder nursing

Primary outcomes

  1. Incidence of urinary tract infection

    Time frame: Within 4 weeks after subject enrollment

    Count the occurrence of urinary tract infection within 4-week follow-up and calculate infection incidence of each group.

  2. Post-void residual urine volume

    Time frame: Baseline and 4 weeks after intervention

    Bladder residual urine volume is measured by ultrasonic examination at baseline and after 4 weeks of nursing intervention to compare the difference between two groups.

Secondary outcomes

  1. Self-care ability and quality of life score

    Time frame: Baseline and 4 weeks after intervention

    Standardized scale scoring for self-care and quality of life before and after 4-week transitional nursing.

Sponsors and collaborators

Lead sponsor

Xiamen University

Other

Registry information

Official study title

Effects Of App-Supported Transitional Care On Bladder Function And Quality Of Life in Patients With Neurogenic Bladder After Incomplete Spinal Cord Injury: A Randomised Controlled Trial

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 11, 2026
Registry last updated
Jun 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.